Trial Profile
Effect of RTL1000 on Complement-Dependent T Effector cell activation in MS.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs RTL 1000 (Primary)
- Indications Multiple sclerosis
- Focus Pharmacodynamics
- 26 Oct 2011 Study phase estimated
- 26 Oct 2011 New trial record